Abstract
A clinically important prolongation of effects have been achieved with two compounds, salmeterol and formoterol, who seem to have an increased binding to the cellular membrane, a binding that not exclusively is related to theβ-receptor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Svedmyr N, Löfdahl CG (1987) Physiology and pharmacodynamics ofβ-adrenergic agonists. In: Jenne J (ed) Drug therapy for asthma. Marcel Dekker, New York pp 177–211
Britton J, Hanley SP, Garrett HV, Hadfield JW, Tattersfield AE (1988) Dose related effects of salbutamol and ipratropium bromide an airway calibre and reactivity in subjects with asthma. Thorax 43:300–305
Ida H (1976) Comparison of the action of BD40A and some otherβ-adrenoceptor stimulants on the isolated trachea and atria of the guinea-pig. Arzneimittelforschung 26:839–842
Bradshaw J, Brittain RT, Coleman RA, Jack D, Kennedy I, Lunts LHC, Skidmore IF (1987) The design of salmeterol, a long-acting selectiveβ 2-adrenoceptor agonist. Br J Pharmacol 92:590P
Löfdahl CG, Svedmyr N (1986) Effect duration of inhaled formoterol, a newβ 2-adrenoceptor agonist, compared to salbutamol in asthmatic patients. Acta Pharmacolog Toxicol (Suppl 5(II)) 229 (A1358)
Löfdahl CG, Svedmyr N (1989) Formoterol fumarate, a newβ2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Allergy 44:264–271
v Berg A, Berdel D, Buhr W. Ein inhalativesβ2. Adrenergikum mit Langzeitwirkung in der Akut und Dauertherapie beim Asthma bronchiale im Kindesalter. Atemw. Lungeanerkh. 1988:14(Suppl 2) S128-S132
Löfdahl CG Unpublished results.
Ullman U, Svedmyr N (1988) Salmeterol, a new long acting inhaledβ2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43:674–678
Nials AT, Coleman RA (1987) The interaction between salmeterol andβ-adrenoceptor blocking drugs on guinea-pig isolated trachea. Br J Pharmacol 92:540P
Brittain RT, Jack D, Sumner MJ (1988) Further studies on the long duration of action of salmeterol, a new, selective beta2-stimulant bronchodilator. J Pharm Pharmacol 40(Suppl):93P
Decker N, Quennedey MC, Rouot B, Schwarts J, Velly J (1982) Effects of N-aralkyl substitution ofβ-agonists on alpha andβ-adrenoceptor subtypes: Pharmacological studies and binding assays. J Pharm Pharmacol 34:107–112
Ball DI, Coleman RA, Denyer LH, Nials AT, Sheldrick KE (1987) In vitro characterisation of theβ 2-adrenoceptor agonist, salmeterol. Br J Pharmacol 88:591P
Jeppsson AB, Löfdahl CG, Waldeck B, Widmark E (1989) On the predictive value of in vitro experiments in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulmonary Pharmacol 2:81–85
Flavahan NA, Aarhus LL, Rimele TJ, Vanhoutte PM (1985) Respiratory epithelium inhibits bronchial smooth muscle tone. J Appl Physiol 58:834–838
Smith K, Vanhoutte PM (1988) Airway epithelium modulates the responsiveness of porcine bronchial smooth muscle. J Appl Physiol 65:721–727
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Löfdahl, CG. Basic pharmacology of new long-acting sympathomimetics. Lung 168 (Suppl 1), 18–21 (1990). https://doi.org/10.1007/BF02718108
Issue Date:
DOI: https://doi.org/10.1007/BF02718108